619 material Form 8-K filings that 507 companies we cover made with the SEC in December 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Paychex reported fiscal second-quarter results for the three months ended November 30, 2025, with total revenue up 18% to $1.6 billion, and acquired Paycor contributing approximately 17% to Management Solutions revenue growth. GAAP diluted earnings per share fell 4% to $1.10 after $77.0 million of Paycor acquisition-related costs, while adjusted diluted EPS rose 11% to $1.26. The company updated its fiscal 2026 outlook so that adjusted diluted EPS is now expected to grow 10% to 11%, but the GAAP earnings decline and higher acquisition costs are the main offsets for shareholders.
Total revenue was $1.6 billion ($1,557.6 million) for the quarter, up 18% from $1,316.9 million a year earlier.
Diluted EPS was $1.10, down 4%; adjusted diluted EPS was $1.26, up 11%, excluding $77.0 million of acquisition-related costs.
Operating margin was 36.7% versus 40.9% a year earlier; adjusted operating margin was 41.7%.
Fiscal 2026 adjusted diluted EPS growth is now anticipated at 10% to 11%; other guidance is unchanged.
Lamb Weston reported fiscal second-quarter 2026 net sales of $1.6 billion, up 1% from a year earlier, and net income of $62.1 million, compared with a net loss of $36.1 million a year ago. Adjusted diluted EPS fell 5% to $0.69 because adjusted gross profit declined on unfavorable price/mix, and the company reaffirmed its fiscal 2026 guidance and raised its quarterly dividend 3% to $0.38 per share.
Net sales were $1,618.1 million, up 1%; at constant currency they were essentially flat, with volume up 8% and price/mix down 8%.
Diluted EPS was $0.44 versus a loss of $0.25 a year ago; adjusted diluted EPS was $0.69, down 5%.
Fiscal 2026 guidance was reaffirmed: net sales of $6.35 billion to $6.55 billion and adjusted EBITDA of $1.00 billion to $1.20 billion.
The board authorized a 3% dividend increase to $0.38 per share, payable February 27, 2026.
Conagra reported second quarter fiscal 2026 net sales down 6.8% to $3.0 billion and a GAAP diluted loss of $1.39 per share, driven by $968 million in non-cash goodwill and brand impairment charges. Adjusted EPS was $0.45, and the company reaffirmed its fiscal 2026 adjusted EPS guidance of $1.70 to $1.85, but lowered its adjusted equity earnings outlook to about $170 million from about $200 million.
Net sales were $3.0 billion, down 6.8%; organic net sales fell 3.0%
GAAP net loss attributable to Conagra was $664 million; goodwill impairment charges were $771.3 million and other intangible impairment charges were $197.0 million
Adjusted EPS was $0.45; prior-year second quarter GAAP diluted EPS was $0.59
Fiscal 2026 adjusted EPS guidance of $1.70 to $1.85 was reaffirmed; adjusted equity earnings expectation was cut to about $170 million from about $200 million
On December 18, 2025, a Coty subsidiary agreed to sell its remaining 25.8% stake in Wella to KKR-affiliated buyers for $750 million in cash plus a consideration loan note, and the right to 45% of proceeds from any further sale or IPO after KKR's preferred return. Coty expects a preliminary non-cash impairment charge of approximately $200 million in the quarter ending December 31, 2025, and says it plans to use most of the upfront cash to pay down debt.
Buyer is Tides Holdco Limited, with KKR-affiliated entities; upfront consideration is $750 million in cash plus a consideration loan note.
Coty will hold 45% of the ordinary shares of the buyer and has consent rights and a non-voting board observer seat.
Coty expects a material non-cash impairment charge of approximately $200 million in the quarter ended December 31, 2025; the amount is preliminary.
Coty says the Wella proceeds and free cash flow are expected to reduce financial net leverage to about 3x by the end of calendar 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.